Navigation Links
U of M researchers identify possible key to treating, understanding post-traumatic stress disorder
Date:10/28/2010

MINNEAPOLIS / ST. PAUL Minn. (October 28, 2010) University of Minnesota Medical School and Minneapolis Veterans Affair Medical Center researchers have discovered a correlation between increased circuit activity in the right side of the brain and the debilitating, involuntary flashbacks triggered by post traumatic stress disorder (PTSD).

The ability to objectively diagnose PTSD through concrete evidence of neural activity, its impact and its manifestation is the first step towards effectively helping those afflicted with this severe anxiety disorder.

PTSD often stems from war, but also can be a result of exposure to any psychologically traumatic event. The disorder can manifest itself in flashbacks, recurring nightmares, anger or hyper-vigilance.

Using a technique called Magnetoencephalography (MEG), a non-invasive measurement of magnetic fields in the brain, researchers found differences between signals in the temporal and parieto-occipital right hemispheric areas of the brain among those with PTSD. The temporal cortex, in accordance with earlier findings on the effects of its electrical stimulation during brain surgery, is thought to be responsible for the re-living of past experiences.

The research led by Apostolos Georgopoulos, M.D., Ph.D., and Brian Engdahl., Ph.D., both members of the Brain Sciences Center at the Minneapolis VA Medical Center and University of Minnesota is published today in the Journal of Neural Engineering.

It's a major scientific and medical discovery, Georgopoulos said, because the MEG tests reveal a clear difference in activity among the circuitry in the brains of PTSD sufferers in comparison to those without the condition. The findings are something conventional brain scans such as an X-ray, CT, or MRI have failed to demonstrate.

Besides diagnosing those with PTSD, the researchers also are able to judge the severity of a patient's suffering, which means the MEG may be able to be used to gauge the how badly patients are impacted by other brain disorders.

"Having a diagnostic exam capable of confirming post-traumatic stress disorder is critical in treating these patients properly," Georgopoulos said.

Also of particular interest to the scientists: during the study, the brains of PTSD sufferers were in the hyperactive state despite the lack of any immediate external stimulation, evidence found through trial subjects being purposefully put into a "task-free state." This finding is significant because it confirms that PTSD sufferers can relive terrifying memories at any moment regardless of what they are doing.

"Remarkably, the differences we found between the PTSD and the control groups were documented in a task-free state. Without evoking traumatic experiences, and therefore, reflects the status of steady-state neuronal interactions," Georgopoulos said.

The trial involved 80 subjects with confirmed PTSD, many of whom suffer the affliction following military service in Vietnam, Afghanistan and Iraq; 18 subjects in PTSD remission; and 284 healthy subjects.

All participants were required to wear the MEG helmet while fixating on a spot 65 cm in front of them for 60 seconds.

The research is one further step in the attempt to 'biomark' PTSD, particularly as the results gathered from subjects in remission followed a similar but less pronounced pattern to those with PTSD confirmed as their primary diagnosis, in contrast to the healthy subjects.


'/>"/>

Contact: Nick Hanson
hans2853@umn.edu
612-624-2449
University of Minnesota
Source:Eurekalert

Related medicine news :

1. Tumor suppressor acts as oncogene in some cancers, say Mayo Clinic researchers
2. EMBO recognizes 63 researchers for advances in life sciences
3. Newfoundland researchers crack the genetic code of a sudden death cardiac killer
4. Researchers find pathway that drives spread of pediatric bone cancer in preclinical studies
5. Quebec City researchers pave the way for novel treatment of pulmonary hypertension
6. Mount Sinai researchers discover origin of immune cells in the brain
7. UC San Diego researchers identify factor boosting leukemias aggressiveness
8. UCI stem cell researchers to receive $9.35 million in state funding
9. Researchers find better method to help mothers cope with childs cancer and related stress
10. Researchers advocate for more education and attention regarding rare breast cancer
11. Mount Sinai researchers discover why cocaine is so addictive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... devices. Through an educational webinar, they will present the line of epMotion automated ... learn how easy you can automate everyday pipetting tasks. , Ideal for scientists ...
(Date:8/18/2017)... Woodlands, TX (PRWEB) , ... August 18, 2017 ... ... protection assistance and financial planning services to communities in east Texas, is launching ... Pediatric Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... The Golseth ... in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized to provide ... , In early June of this year, Christina and her children returned from out ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that rids the body ... with its product now available through Jet.com. , After 25 years of development, ... drink is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)...  Endo International plc (NASDAQ: ENDP ) ... all known U.S. mesh product liability claims and that ... remaining U.S. claims at reasonable values. Under the agreements, ... quarter of 2017 and continuing through the fourth quarter ... results, the Company intends to increase its mesh product ...
(Date:8/2/2017)... AROMAS, Calif. , Aug. 2, 2017 /PRNewswire/ ... by Continental Who,s Who as a Pinnacle Lifetime ... currently the Key Account Manager at Turing Pharmaceuticals, ... communications, negotiations, troubleshooting and relationship building.                ... has more than 25 years of experience ...
(Date:8/1/2017)... Aug. 1, 2017   CerSci Therapeutics , a ... Texas , has received notice from the National ... of Health (NIH) that it has been awarded a ... over $650,000 in 2017 with an additional $1,000,000 to ... New Drug application of their lead non-opioid drug candidate ...
Breaking Medicine Technology: